Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 1
R&D Momentum
49/100
Pipeline Velocity
6/100
Trial Completion Rate
81/100
Pipeline Concentration
100/100
Pipeline Freshness
0/100
Activity
Last 14 days
Clinical and Basic Investigations Into Smith-Lemli-Opitz Syndrome
Children's Growth and Behavior Study
Natural History Study of Patients With Excess Androgen
Investigations Into Inborn Errors of Cholesterol Synthesis and Related Disorders
Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C
Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency
Androgen Receptor, Implications for Health and Wellbeing: Natural History Study of Individuals With Androgen Insensitivity
A Prospective Natural History Study of Lymphatic Anomalies
Establishment of Genomic and Phenotypic Database for Niemann-Pick Disease, Type C
Clinical and Molecular Analysis of ACTH-Independent Steroid Hormone Production in Adrenocortical Tissue
Investigations of Bone-Related Connective Tissue Disorders
Evaluation and Intervention for Ambulation, Growth, and Basilar Invagination in Osteogenesis Imperfecta
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)